Enact Holdings, Inc. (ACT) Stock Forecast
ACT analyst forecast
as of October 17, 2026- Analyst consensus
- Hold 3.17 / 5 from 6 analysts
- Price target
- $49.40 average of analyst targets
- Upside to target
- +6.7% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $1.21
- 52-week range
- $34.93 – $50.07
ACT analyst ratings
6 analystsNumber of analysts at each rating.
ACT price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ACT earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.20 | $1.16 | $1.21 | $1.12 | +6.7% | 4 |
| Current fiscal year (2026) | $4.85 | $4.77 | $4.89 | $4.61 | +5.1% | 4 |
| Next fiscal year (2027) | $5.03 | $4.75 | $5.25 | $4.85 | +3.7% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ACT revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $317.9M | $314.2M | $322.0M | +2.1% | 4 |
| Current fiscal year (2026) | $1.27B | $1.26B | $1.28B | +2.5% | 4 |
| Next fiscal year (2027) | $1.28B | $1.26B | $1.31B | +1.4% | 4 |
ACT EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ACT revenue: reported and forecast
ACT EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.18 | $1.19 | $1.19 | $1.19 | $1.20 | +1.0% | 1 up · 1 down |
| Current fiscal year (2026) | $4.75 | $4.84 | $4.84 | $4.85 | $4.85 | +2.1% | 0 up · 1 down |
| Next fiscal year (2027) | $4.92 | $5.01 | $5.01 | $5.07 | $5.03 | +2.1% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ACT earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ACT beat in 12 of 12.
What analysts expect from ACT
6 analysts cover Enact; their consensus rating is hold (3.17 on a 1–5 scale, where 5 is a strong buy). The average price target is $49.40, 6.7% above the latest close of $46.28. Analysts expect earnings of $4.85 per share for 2026, +5.1% from a year earlier. For 2027 the average estimate is $5.03 per share on revenue of $1.3 billion. Enact beat the EPS estimate in 12 of the last 12 quarters.
Related: ACT income statement, ACT key metrics, ACT chart. See the ACT stock overview for the latest quote and news.
ACT forecast FAQ
What is Enact's price target?
The average analyst price target for Enact is $49.40, 6.7% above the latest close of $46.28.
Is Enact a buy, hold or sell?
Of 6 analysts covering Enact, 1 rate it a strong buy, 0 a buy, 4 a hold, 1 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Enact's EPS forecast?
Analysts forecast $4.85 per share for 2026 (range $4.77 to $4.89); for 2027 the estimate is $5.03.
What is Enact's revenue forecast?
The average revenue estimate for 2026 is $1.3 billion, growth of 2.5%; for 2027 it is $1.3 billion.
When does Enact report earnings?
Enact is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $1.21.
Does Enact usually beat earnings estimates?
Enact reported EPS at or above the analyst estimate in 12 of the last 12 quarters.